Meropenem induced mixed hepatocellular and cholestatic hepatitis: A report of two cases
PDF
Cite
Share
Request
Case Report
P: 64-66
June 2018

Meropenem induced mixed hepatocellular and cholestatic hepatitis: A report of two cases

Gulhane Med J 2018;60(2):64-66
1. Turkish Ministry of Health, Gulhane Teaching and Research Hospital, Internal Medicine Clinic, Department of Internal Medicine, Ankara, Turkey
2. University of Health Sciences, Gülhane Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey
No information available.
No information available
Received Date: 05.03.2018
Accepted Date: 23.03.2018
Publish Date: 15.06.2018
PDF
Cite
Share
Request

ABSTRACT

Drug-induced liver injury (DILI) is common clinic issue in clinical practice and might be induced by almost all drugs. Antibiotics (especially beta-lactams) are one of the leading cause due to their widespread use. Albeit rare, meropenem may cause DILI, even shortly after its administration. Here we report our experience of two cases with cholestatic hepatitis that occured after meropenem use. In the differential diagnosis of liver enzyme abnormalities after meropenem treatment, physicians should also prompt suspicion of an adverse drug reaction.